A disturbing trend has emerged in the Netherlands, with an alarming rise in self-poisoning incidents linked to the unsupervised use of slimming drugs. The toxicological centre NVIC has sounded the alarm, reporting a significant increase in cases of poisoning from these medications.
In a recent article by DutchNews.nl, it was revealed that the number of poisoning reports has skyrocketed, with 105 cases so far in 2025, compared to just 75 for the entire year of 2024 and a mere 41 in 2023. This surge in incidents is a cause for serious concern.
But here's where it gets controversial: most of these cases involve a drug called semaglutide, the active ingredient in brands like Ozempic, Wegovy, and Rybelsus. The issue? People are buying these medications online without consulting a doctor, which can lead to dangerous side effects.
The symptoms of poisoning include nausea, vomiting, and gastrointestinal issues. However, NVIC head Dylan de Lange warns that these are just the reported cases. "There are many more that we don't hear about," he said. De Lange further explained that in some severe cases, individuals ended up severely dehydrated and required emergency medical care.
"People who overindulge in these drugs risk developing gastroparesis, a condition that affects the stomach muscles and impairs proper food processing," de Lange emphasized. This highlights the potential long-term consequences of unsupervised use.
The increasing popularity of these appetite suppressants has led to a rise in studies investigating rare but serious side effects. These include acute kidney failure, liver infections, muscle wasting, and eye blood vessel infections that can result in blindness. It's a stark reminder of the potential dangers associated with these drugs.
In 2024, approximately 120,000 people in the Netherlands were prescribed slimming drugs. Currently, insurance coverage for weight-loss medications is limited to individuals with a body mass index of at least 35 and type II diabetes. However, a government-backed survey earlier this year revealed that 90% of respondents believe weight-loss drugs should be included in basic insurance packages.
This raises the question: should we be more cautious about the availability and accessibility of these drugs? With the potential for severe side effects and the increasing number of poisoning cases, it's a topic that deserves further discussion and consideration. What are your thoughts on this issue? Feel free to share your opinions and engage in a thoughtful conversation in the comments below.
